Non-Alcoholic Fatty Liver Disease Trial, Recruiting (NCT04232566)

Non-Alcoholic Fatty Liver Disease Trial, Recruiting NCT04232566 Sponsor: Mayo Clinic Condition: Non-Alcoholic Fatty Liver Disease

Printed from Voxsanity (voxsanity.com.au) — NCT04232566 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Non Alcoholic Fatty Liver Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are scheduled to have gastric bypass surgery
You have been confirmed to have either no liver scarring (F=0) or significant liver scarring (F greater than 2), based on a specific liver assessment test
You are between 30 and 70 years old
Your Body Mass Index (BMI) is greater than 40 kg/m²(confirm with trial site if unsure of your BMI)
You have a negative pregnancy test (required for women only)
Your thyroid hormone levels (TSH) are within the normal range based on a blood test

Who may not be able to join:

You have been diagnosed with an autoimmune disease (a condition where your immune system attacks your own body)
You have tested positive for Hepatitis B or Hepatitis C
You drink alcohol heavily on a regular basis
You are currently a smoker or have an active smoking history
You currently have or have previously had cancer
You have a history of asthma
You have a history of COPD (a chronic lung condition)
You currently take Plavix (clopidogrel) or Coumadin (warfarin), which are blood-thinning medications
You have donated blood within the past 2 months
You are currently receiving steroid (glucocorticoid) therapy
You regularly take antihistamine medications (such as allergy tablets)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Elena Anna O De Filippis, Mayo Clinic

Phone: 480-301-4164

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04232566

Sponsor: Mayo Clinic

Phase: Not Applicable

Status: Recruiting

Condition: Non-Alcoholic Fatty Liver Disease

Trial contact: 480-301-4164

More information: https://clinicaltrials.gov/study/NCT04232566

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are scheduled to have gastric bypass surgery
You have been confirmed to have either no liver scarring (F=0) or significant liver scarring (F greater than 2), based on a specific liver assessment test
You are between 30 and 70 years old
Your Body Mass Index (BMI) is greater than 40 kg/m²(confirm with trial site if unsure of your BMI)
You have a negative pregnancy test (required for women only)
Your thyroid hormone levels (TSH) are within the normal range based on a blood test

Who may not be able to join:

You have been diagnosed with an autoimmune disease (a condition where your immune system attacks your own body)
You have tested positive for Hepatitis B or Hepatitis C
You drink alcohol heavily on a regular basis
You are currently a smoker or have an active smoking history
You currently have or have previously had cancer
You have a history of asthma
You have a history of COPD (a chronic lung condition)
You currently take Plavix (clopidogrel) or Coumadin (warfarin), which are blood-thinning medications
You have donated blood within the past 2 months
You are currently receiving steroid (glucocorticoid) therapy
You regularly take antihistamine medications (such as allergy tablets)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Mayo Clinic

Registry

ClinicalTrials.gov

Start date

20 February 2022

Est. completion

31 December 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Liver fibrosis; Adipose tissue inflammation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov